Skip to main content
Premium Trial:

Request an Annual Quote

Startup Biomarker Instrument Firm Avantra Biosciences Raises $7M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Newly formed Avantra Biosciences has raised $7 million, it disclosed in a document filed with the US Securities and Exchange Commission on Monday.

The Woburn, Mass.-based firm said the funds raised were in the form of equity and will not be used for a merger, acquisition, exchange offer, or other business combination transaction. It did not specify how the money will be used, but last month GenomeWeb Daily News' sister publication ProteoMonitor reported that Avantra plans to launch the Avantra Biomarker Workstation and accompanying assays early next year after closing of the Series B round.

Avantra was launched at the end of last year by Courtagen Capital Group from the ashes of Decision Biomarkers. Courtagen bought the assets of Decision Biomarkers after the protein biomarker technology firm shuttered its business and filed for Chapter 7 bankruptcy.

The Biomarker Workstation was developed by Decision Biomarkers and is used for biomarker detection.

In its SEC filing, Avantra lists Brian McKernan as its CEO and Brendan McKernan as its president.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.